Showing posts with label Lab-on-a-Chip Device Market. Show all posts
Showing posts with label Lab-on-a-Chip Device Market. Show all posts

Friday 4 December 2020

Lab-on-a-Chip Device Market 2018 competitive analysis segmentation industry highlights and forecasts till 2023

Lab-on-a-Chip Device Market Information: Product (Instruments, Reagents & Consumables), Technology (Microarrays, Microfluidics), Application (Point of Care Diagnostics), and End-User (Biotechnology and Pharmaceutical Companies) – Global Forecast Till 2023

Market Highlights

The Lab-on-a-Chip Market is forecasted to exhibit robust growth registering a CAGR of 10% during the forecast period. The global Lab-on-a-Chip Market size is majorly driven by increasing application of lab on chip devices in the medical field in the diagnosis of various infectious diseases which eases sample handling and yields efficient results in a snap of time. Similarly, the use of lab-on-a-chip devices in research purposes is gaining traction due to easy portability, automated biochemical assays, and huge sample handling provision. Moreover, rising demand for miniature devices, advancing fabrication technology, research on biosensors and biomarkers, and economic feasibility of lab-on-a-chip devices are expected to spur the market growth. However, initial higher purchasing rate, as well as lack of awareness about the use of lab-on-a-chip devices in middle-income countries, are major restraints to the market growth.

Get Latest Sample Copy @ https://www.marketresearchfuture.com/sample_request/6215

Regional Analysis

Americas is the market leader and has an attractive market for lab on chip devices owing to increasing advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases.  Additionally, factors such as increasing number of genomic and proteomics research labs government initiatives and funding for research, development of advanced medical treatment options, and rising demand for portable devices are likely to enhance the growth of Lab-on-a-Chip Market size in the American region. For instance, According to stats presented in the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years in the U.S. received an influenza vaccine. Due to the alarming rate of chronic as well as infectious diseases, use of lab-on-a-chip devices is accelerated due to its precision in diagnosis and multiple samples handling feature.

Europe is the second largest market and holds a healthy share in the global Lab-on-a-Chip Market size due to major driving factors such as the flourishing medical device market, favorable government initiatives to promote life-science and clinical research, rising average per capita income of individuals. For instance, the European Commission stated that the R&D spending by the pharmaceuticals and biotechnology sectors grew by 8.7% in 2014. This investment in R&D along with the ongoing legislative reforms is expected to have a positive impact on the Lab-on-a-Chip Market size.

The Asia-Pacific is expected to be the fastest growing market owing to the faster adaptation of healthcare technology, increasing patient pool of chronic and infectious diseases, government initiatives of healthcare reform, increasing number of CROs and research projects on environmental issues. Furthermore, key medical device players have set up their regional headquarters and manufacturing plants in Singapore, China, Japan,  and Australia thus, boosting the growth of Lab-on-a-Chip Market size.

The Middle East & Africa is expected to show the least growth in the market due to some major factors such as lack of awareness, limited access and availability of treatment facilities. In the Middle East, the United Arab Emirates is the largest market share owing to the development of the healthcare industry and sound economic status of inhabitants. However, this area has the possibility to grow during the forecast period as due to increasing outbreak of new opportunistic pathogen associated diseases like Ebola, Zika Virus, and Hepatitis B which has attracted key players to set up their R&D centers in this region.

Access Report @ https://www.marketresearchfuture.com/reports/lab-on-a-chip-device-market-6215

Segmentation:

The global LoC device market can be segmented by product, technology, application, and end-user. 

Product-wise, the market includes instruments, reagents & consumables, software, and others. Researchers from Biozentrum of the University of Basel and Max Planck Institute in Dresden have set up a LoC along with automatic analysis software that can study single cell responses. 

Based on application, the market comprises genomics, proteomics, the point of care diagnostics, drug discovery and others. LoC has revamped genomic field of study by taking down the time of detection by a considerable margin. Researchers from Griffith University’s Queensland Micro and Nanotechnology Centre have discovered new ways to screen drugs by using LoC that would reduce the drug testing time considerably.

By end-user, the market consists, hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.

Industry Trends:

A Scotland based company uFraction8 Ltd. has recently come up with a microfluidic-based filtration system which is an essential part in remodeling the LoCs. Other innovations are also startling and can revolutionize the segment by taking the practice some light years ahead. Researchers from the Brigham Young University have now developed a technology that can 3D print LoC.

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

 

Sunday 29 November 2020

News: Lab-on-a-Chip device market | Growth Factors | Demand| Size | Share and Trends

 

Market Insights

According to the reports published by Market Research Future, the global lab-on-a-chip device market is projected to exhibit robust growth with registering a CAGR of 10% by the year 2023. The lab-on-a-chip device brings diverse laboratory processes on a minimally sized integrated circuit and thus, eases the sample handling process and delivers results with excellent efficiency.

Latest Free Sample Copy Available @ https://www.marketresearchfuture.com/sample_request/6215

With that, quick sampling with precise results within a short span of time can easily solve problems such as drug wastage as well as drug resistance. By this, it enables the patients to have timely diagnosis and ensures adequate time to start with necessary medical procedures. Therefore, lab-on-a-chip offers optimization of the process and gains traction in various corners of the pharmaceutical sector. Such eminent features of the lab-on-a-chip device are propelling the global lab-on-a-chip device market in exponential ways. 

Global Lab-on-a-Chip Device Market: Drivers & Trends

Presently, the lab-on-a-chip device is experiencing immense popularity in diagnosing of various infections and chronic diseases. On this note, the factors that are airing the demand for this lab-on-a-chip are its portability, automated sample handling, and comfortable configuring and the potential to revolutionize the biomedical field. These are also contributing to the lab-on-a-chip device market to expand drastically in medical use across the globe. 

Similarly, other factors such as multiple advantages of microfluidic technology, rise in demand for diagnostics, expanding global population with the prediction of significant growth opportunities, and technological advancements in laboratories have amplified the penetration and growth of the lab-on-chips market globally. Also, the use of lab-on-a-chip devices mainly in research purposes is gaining the major traction owing to its easy portability feature, automated biochemical assays, and massive sample handling provision, which is making devices reliable and usable in a very convenient way. Such factors are streaming to take the global lab-on-chips market to new heights at a higher CAGR during the forecasted period.

Market Segmentation

According to reports of MRFR, the global lab-on-a-chip market has been segmented by product, technology, application, and end user. 

By the mode of product, the market is segmented into instruments, reagents & consumables, software, and others.


By the mode of technology, the market is segmented into microarrays, microfluidics, tissue biochip, and others.

By the mode of the application, the market is segmented into genomics, proteomics, the point of care diagnostics, drug discovery, and others.

Lastly, accounting on the end-user, the market is segmented as hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.

Regional Outlook

On a geographical note, the global lab-on-a-chip device market has covered the main regions of America, Europe, Asia Pacific, and the Middle East & Africa.

Among all, the Americas is the market leader and has an attractive lab-on-a-chip devices market growth owing to mounting advances in molecular biology and genetic engineering techniques as well as increasing prevalence of infectious diseases.  Also, factors such as swelling genomic and proteomics research labs, government initiatives and funding for research, development of progressive medical treatment options, and rising demand for portable devices are possible to augment the growing lab-on-a-chip device market in the American region. According to stats by the Centers for Disease Control and Prevention report in the year 2017, around 49.9% of the children between the ages of 6 months to 17 years received an influenza vaccine. Owing to the distressing rate of chronic as well as infectious diseases, use of lab-on-a-chip devices was accelerated in diagnosis and multiple samples handling which catered the best use of it. 

Similarly, Europe is also considered as the second largest market and holds a healthy share in the global Lab-on-a-Chip device market owing to main driving factors such as the thriving medical device market, favorable government initiatives to promote clinical research, rising average per capita income. The European Commission also quantified that the research & development by the pharmaceuticals and biotechnology sectors grew by 8.7% in 2014. This investment in R&D, along with the enduring legislative reforms, are predictable to have a constructive impact on the Lab-on-a-Chip device market in the years to come. 

While in the Asia-Pacific region, it is expected that this region will be the fastest growing market owing to the more rapid adaptation of healthcare technology, increasing chronic patients and infectious diseases, government initiatives of healthcare reform, a growing number of CROs and research projects on environmental issues. Furthermore, key medical device players have already set up their regional headquarters and manufacturing plants in countries such as China, Japan, and Australia; thus, boosting the growth of Lab-on-a-Chip device market during the forecast period.

Lastly, the Middle East & Africa is also expected to portray the least growth in the market owing to lack of awareness, limited access, and availability of treatment facilities. While, in the Middle East, the United Arab Emirates has the largest market share owing to the development of the healthcare industry and overall economic status in this region. 

Key Players

Market Research Future (MRFR) distinguishes the following companies as the key players in the global lab-on-a-chip device market. The names are Becton, Dickinson And Company, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Abbott Laboratories, F. Hoffmann-La Roche AG, PerkinElmer, Inc., IDEX Corporation, Thermo Fisher Scientific, Inc., Cepheid Inc., and Biacore AB.

OBTAIN RESEARCH REPORT DETAILS WITH TOC @ https://www.marketresearchfuture.com/reports/lab-on-a-chip-device-market-6215

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com






Thursday 4 June 2020

Worldwide Lab-on-a-Chip Device Market Trends, Growth Outlook to Forecast by 2023

Lab-on-a-Chip Market Overview:
The global Lab-on-a-Chip Market to experience a staggering growth with a CAGR of 10% during the forecast period (2018-2023), in an extensive report reveals Market Research Future (MRFR). Lab-on-a-chip brings in diverse laboratory processes on a minimally sized integrated circuit and eases the sample handling process and within a flicker delivers results with excellent efficiency. 
Drivers and Restraints:
Quick sampling and precise results, within a very short span of time, can solve problems such as drug wastage, and drug resistance. This also enables patients to have a timely diagnosis and ensures enough time to start the necessary medical procedures. LoC offers optimization of the process and gains traction in the process enough to enjoy accolades from the various corners of the medical sector. 
LoC is experiencing popularity in diagnosing various infections and chronic diseases along with multiple tests of diverse disciplines such as Botany. Factors that are airing the demand for LoC are its portability, automated sample handling, and easy configurability. Also, the microfluidic LoC has the potential to revolutionize the biomedical field.
However, a few factors can impede the market growth such as high initial cost and lack of awareness in countries with people mostly belonging to the middle-income group. But LoC is slowly becoming an integral part of the diagnosing procedure which can marshal the market to overcome such irritants.
Industry Trends:
A Scotland based company uFraction8 Ltd. has recently come up with a microfluidic-based filtration system which is an essential part in remodeling the LoCs. Other innovations are also startling and can revolutionize the segment by taking the practice some light years ahead. Researchers from the Brigham Young University have now developed a technology that can 3D print LoC.
Segmentation:
The global Lab on a chip market can be segmented by product, technology, application, and end-user. 
Product-wise, the market includes instruments, reagents & consumables, software, and others. Researchers from Biozentrum of the University of Basel and Max Planck Institute in Dresden have set up a LoC along with automatic analysis software that can study single cell responses. 
Based on application, the market comprises genomics, proteomics, the point of care diagnostics, drug discovery and others. LoC has revamped genomic field of study by taking down the time of detection by a considerable margin. Researchers from Griffith University’s Queensland Micro and Nanotechnology Centre have discovered new ways to screen drugs by using LoC that would reduce the drug testing time considerably.
By end-user, the market consists, hospitals and clinics, biotechnology and pharmaceutical companies, forensic laboratories, diagnostics centers, and academic & research institutes.
Regional Analysis:
Region-wise the market covers the Americas, Europe, the Asia Pacific (APAC), and the Middle East & Africa (MEA).
The Americas are leading the market owing to their huge expenditure in molecular biology and genetic engineering to counter infectious diseases. Genomic and proteomic researches are also spurring the demand for such technology and accordingly LoC is getting significant funds from various organizations. Its precision in diagnosis and ability to handle multiple samples simultaneously are also proving effective for chronic disease treatment. 
Europe is the second largest market due to its flourishing medical device market and favorable government initiatives that are funding researches. Growing per-capita income of individuals is also proving to be a significant factor.
The APAC is expected to be the fastest growing region as it has a huge patient pool suffering from diverse kind of chronic and infectious diseases. Also, the region is adopting the latest technologies. Governments are promoting favorable market conditions due to which a lot of international players are setting up their factories and laboratories in this region.
The MEA is expected to register a meager market share as the region lacks awareness and proper facilities. The United Arab Emirates holds the largest market share as it has adequate healthcare facilities and the economic status of the citizens. 

Market Dashboard:

The competitive market is banking much on research & developments and merger & acquisitions. For instance, Becton-Dickinson and Company have recently acquired C. R. Bard to expand their portfolio. Agilent Technologies has also acquired Advanced Analytical Technologies, Inc. in a bid to explore much of electrophoresis space. 

Key companies that are playing contributing the most in the market are Becton-Dickinson and Company, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad Laboratories, Abbott Laboratories, Hoffmann-La Roche AG, PerkinElmer, Inc., IDEX Corporation, Thermo Fisher Scientific, Inc., Cepheid Inc., Biacore AB, and others.

NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:                                    
Akash Anand                                                                       
Market Research Future
+1 646 845 9312